July 30, 2026 — RNews

#pharmacoepidemiology — Thursday, July 30, 2026 (1 items)

hot top new

← prev day next day →

0

Cardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes. (nature.com)

Liu PY … Sung JM Nature Communications 2026-07-30

#cardiovascular #heart failure #diabetes #nephrology #pharmacoepidemiology